Metagenomi RuvC domain enzymes, gene editing patent
Summary
The European Patent Office published patent application EP3924482A1 for Metagenomi Therapeutics, Inc., covering enzymes with RuvC domains used in gene editing applications. The patent designates all EU member states and several other European countries. Inventors include Brian Thomas, Christopher Brown, Rose Kantor, and others.
What changed
The EPO published a patent application for RuvC domain enzymes filed by Metagenomi Therapeutics, Inc. The patent covers gene editing technology including applications in C12N 9/22 (nucleic acid enzymes), C12N 15/113 (nucleic acid sequences), and C12N 15/90 (stable integration of nucleic acids). The patent designates all EU member states and other European countries.
Gene editing companies, biotech firms, and pharmaceutical developers should review the patent claims to assess potential licensing needs or freedom-to-operate considerations in the EU market.
What to do next
- Monitor for updates
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ENZYMES WITH RUVC DOMAINS
Publication EP3924482A1 Kind: A1 Apr 01, 2026
Applicants
Metagenomi Therapeutics, Inc.
Inventors
THOMAS, Brian, BROWN, Christopher, KANTOR, Rose, DEVOTO, Audra, BUTTERFIELD, Cristina, ALEXANDER, Lisa, GOLTSMAN, Daniela S. A., LIU, Jason
IPC Classifications
C12N 9/22 20060101AFI20230224BHEP C12N 15/113 20100101ALI20230224BHEP C12N 15/10 20060101ALI20230224BHEP C12N 15/90 20060101ALI20230224BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.